NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Dollar change -0.32
Percentage change -3.35	%

Peers: PFE MRK JNJ NVS ABBV LLY BMY GSK AZN BIIB

| Held by: IJR VTI VB VBR VXF IJS SPSM SLYV DES VYM

Index	-	P/E	3.19	EPS (ttm)	2.89	Insider Own	0.37%	Shs Outstand	259.96M	Perf Week	6.10%
Market Cap	2.40B	Forward P/E	2.26	EPS next Y	4.08	Insider Trans	8.45%	Shs Float	258.99M	Perf Month	-28.69%
Income	750.00M	PEG	2.68	EPS next Q	0.94	Inst Own	80.40%	Short Float	6.16%	Perf Quarter	-38.16%
Sales	6.29B	P/S	0.38	EPS this Y	-6.05%	Inst Trans	-1.61%	Short Ratio	2.77	Perf Half Y	-42.98%
Book/sh	2.10	P/B	4.39	EPS next Y	5.76%	ROA	5.99%	Short Interest	15.96M	Perf Year	-56.05%
Cash/sh	2.10	P/C	4.38	EPS next 5Y	1.19%	ROE	254.24%	52W Range	8.01 - 23.10	Perf YTD	-38.20%
Dividend Est.	0.25 (2.75%)	P/FCF	3.08	EPS past 5Y	-23.49%	ROI	7.91%	52W High	-60.09%	Beta	0.56
Dividend TTM	0.86 (9.33%)	Quick Ratio	1.15	Sales past 5Y	-6.67%	Gross Margin	57.18%	52W Low	15.11%	ATR (14)	0.60
Dividend Ex-Date	May 12, 2025	Current Ratio	1.67	EPS Y/Y TTM	-28.91%	Oper. Margin	22.32%	RSI (14)	44.59	Volatility	3.91% 4.33%
Employees	10000	Debt/Eq	16.52	Sales Y/Y TTM	-0.84%	Profit Margin	11.92%	Recom	3.00	Target Price	14.00
Option/Short	Yes / Yes	LT Debt/Eq	16.49	EPS Q/Q	-57.16%	Payout	33.59%	Rel Volume	0.92	Prev Close	9.54
Sales Surprise	0.32%	EPS Surprise	14.09%	Sales Q/Q	-6.72%	Earnings	May 01 BMO	Avg Volume	5.76M	Price	9.22
SMA20	3.86%	SMA50	-18.16%	SMA200	-40.77%	Trades		Volume	5,303,652	Change	-3.35%

Date	Action	Analyst	Rating Change	Price Target Change
May-02-25	Downgrade	Evercore ISI	Outperform → In-line
Sep-06-24	Downgrade	JP Morgan	Neutral → Underweight	$18 → $20
Nov-03-23	Downgrade	Goldman	Buy → Neutral	$33 → $16
Sep-21-23	Initiated	Barclays	Overweight	$28
Mar-16-23	Initiated	Raymond James	Outperform	$33
Oct-14-22	Downgrade	BofA Securities	Neutral → Underperform	$27 → $25
Sep-06-22	Upgrade	Piper Sandler	Neutral → Overweight	$37 → $34
Aug-05-22	Downgrade	BofA Securities	Buy → Neutral	$40 → $37
Apr-27-22	Initiated	Goldman	Buy	$40
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight	$35
Oct-07-21	Initiated	Piper Sandler	Neutral	$35
Sep-01-21	Initiated	BofA Securities	Buy	$43
Jul-22-21	Initiated	Citigroup	Buy	$35
Jun-15-21	Initiated	JP Morgan	Neutral	$38
Jun-11-21	Initiated	Morgan Stanley	Equal-Weight	$33
Jun-10-21	Initiated	Evercore ISI	Outperform

Show Previous Ratings

May-27-25 07:30AM	US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon HADLIMA (adalimumab-bwwd) Injection (Business Wire) +5.18%
May-20-25 12:42PM	Why Organon & Co.'s (OGN) Surged Last Week (Insider Monkey)
May-06-25 09:00AM	Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
May-05-25 12:35AM	3 Value Stocks with Questionable Fundamentals (StockStory) -9.07%
May-02-25 02:06PM	Organon price target lowered to $10 from $11 at BofA (TipRanks)
10:00AM	Loading…
10:00AM	Why The Low Payout Ratio Did Not Stop The Dividend Cut For Organon (Seeking Alpha)
May-01-25 11:31AM	Organon & Co. (OGN) Q1 2025 Earnings Call Transcript (Seeking Alpha) -26.91%
10:30AM	Organon (OGN) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
08:10AM	Organon (OGN) Q1 Earnings Surpass Estimates (Zacks)
07:00AM	Organon Reports Results for the First Quarter Ended March 31, 2025 (Business Wire)
Apr-28-25 09:15AM	Countdown to Organon (OGN) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
Apr-27-25 01:13PM	3 Cash-Producing Stocks with Questionable Fundamentals (StockStory)
Apr-25-25 06:00PM	Organon (OGN) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
10:00AM	BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
09:00AM	Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
10:01AM	Loading…
Apr-24-25 10:01AM	Analysts Estimate Organon (OGN) to Report a Decline in Earnings: What to Look Out for (Zacks) +5.48%
Apr-22-25 07:10AM	Elevance Health (ELV) Surpasses Q1 Earnings and Revenue Estimates (Zacks) +5.74%
Apr-21-25 05:25PM	Medpace (MEDP) Q1 Earnings and Revenues Beat Estimates (Zacks)
Apr-16-25 02:41PM	IYH: Healthcare Dashboard For April (Seeking Alpha)
Apr-15-25 05:00PM	Organon Appoints Ramona A. Sequeira to the Companys Board of Directors (Business Wire)
07:31AM	Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025 (Business Wire)
Apr-14-25 06:00PM	Organon (OGN) Laps the Stock Market: Here's Why (Zacks)
09:00AM	Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know (Zacks)
Apr-10-25 09:13AM	Strength Seen in Organon (OGN): Can Its 8.5% Jump Turn into More Strength? (Zacks) -9.57%
Apr-08-25 09:21PM	Lightning Round: ServiceNow is an expensive stock in a market that no longer loves expensive stocks (CNBC TV) -6.95% +8.50%
05:07AM	Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment (StockStory)
Apr-07-25 05:06AM	Organon (OGN): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
Apr-03-25 05:50PM	Organon (OGN) Stock Moves -1.83%: What You Should Know (Zacks) -9.69%
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Apr-02-25 12:10PM	Why Organon (OGN) Could Beat Earnings Estimates Again (Zacks)
08:50AM	Loading…
08:50AM	Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings (Zacks)
Apr-01-25 09:00AM	Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock (Zacks) -5.10%
07:30AM	Organon Acquires TOFIDENCE (tocilizumab-bavi), a Commercialized Biosimilar to ACTEMRA (tocilizumab) Injection, for Intravenous Infusion in the U.S. (Business Wire)
Mar-28-25 05:50PM	Organon (OGN) Stock Moves -0.34%: What You Should Know (Zacks)
06:00AM	European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta (pertuzumab) Biosimilar Candidate HLX11 (Business Wire)
Mar-27-25 06:00PM	Organon (OGN) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
Mar-21-25 05:50PM	Organon (OGN) Stock Declines While Market Improves: Some Information for Investors (Zacks)
Mar-19-25 09:00AM	Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Mar-10-25 12:01AM	MAY HEALTH APPOINTS SEASONED MEDTECH EXECUTIVE, COLBY HOLTSHOUSE, AS PRESIDENT AND CEO (PR Newswire)
Mar-08-25 09:00AM	New Analysis of Organon's VTAMA (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older (Business Wire)
Feb-13-25 07:30AM	Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2024 (Business Wire) +11.02%
Jan-23-25 07:30AM	Organon To Report Fourth Quarter and Full Year 2024 Results and Host Conference Call on February 13, 2025 (Business Wire)
Jan-12-25 09:27AM	Is Organon Co. (OGN) the Best Medical Stock to Buy Under $20? (Insider Monkey)
Dec-19-24 07:30AM	Organon To Present at the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-17-24 07:40AM	FDA approves Organons VTAMA cream, 1% for the treatment for AD (TipRanks)
Dec-16-24 07:30AM	FDA Approves VTAMA (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older (Business Wire)
Nov-05-24 07:29AM	Update on FDA Review of VTAMA (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older (Business Wire)
Oct-31-24 07:30AM	Organon Reports Results for the Third Quarter Ended September30, 2024 (Business Wire)
04:43AM	Shanghai Henlius Biotech, Organon announce FDA acceptance of BLA for HLX14 (Pharmaceutical Business Review)
Oct-30-24 06:00AM	US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab) (Business Wire)
Oct-28-24 09:25AM	Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA (tapinarof) Cream, 1% (GlobeNewswire)
Oct-09-24 09:35AM	Organon (OGN) Loses -9.91% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
07:30AM	Organon to Report Third Quarter 2024 Results and Host Conference Call on October 31, 2024 (Business Wire)
Oct-08-24 08:01AM	Organon Canada Promotes Geneviève Gauthier as Executive Director, Corporate Affairs and Community Engagement and Appoints Jeffrey Malawski as Executive Director, Women's Health and Established Brands (PR Newswire)
Oct-02-24 02:05PM	Final Trades: Organon, Howmet and the PSQ (CNBC TV)
Sep-30-24 06:00AM	Primary Endpoint Met in Phase 3 Comparative Clinical Study of Perjeta (pertuzumab) Biosimilar Candidate HLX11 (Business Wire)
Sep-26-24 09:50AM	Organon Canada and the Alberta Women's Health Foundation unite to raise awareness and advocate for universal access to contraception in Canada (PR Newswire)
Sep-25-24 09:05AM	Are Options Traders Betting on a Big Move in Organon (OGN) Stock? (Zacks)
Sep-18-24 07:30AM	Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA (tapinarof) Cream, 1% (GlobeNewswire)
Aug-20-24 07:30AM	Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets (Business Wire)
Aug-06-24 07:30AM	Organon Reports Results for the Second Quarter Ended June 30, 2024 (Business Wire) -7.63%
Aug-02-24 08:48AM	Do Options Traders Know Something About Organon (OGN) Stock We Don't? (Zacks)
Jul-24-24 12:00PM	Organon (OGN) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
Jul-09-24 06:00PM	Organon (OGN) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
07:30AM	Organon To Report Second Quarter 2024 Results and Host Conference Call on August 6, 2024 (Business Wire)
Jun-28-24 09:41AM	Do Options Traders Know Something About Organon (OGN) Stock We Don't? (Zacks)
Jun-26-24 06:00PM	Organon (OGN) Stock Sinks As Market Gains: Here's Why (Zacks)
01:35PM	Value Investing Is Back! 3 Stocks With Strong Fundamentals to Buy Now (InvestorPlace)
09:00AM	Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Jun-20-24 06:00PM	Organon (OGN) Advances While Market Declines: Some Information for Investors (Zacks)
Jun-12-24 09:00AM	Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jun-03-24 09:35AM	Organon (OGN) Just Overtook the 20-Day Moving Average (Zacks)
May-30-24 09:00AM	Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know (Zacks)
May-24-24 06:00AM	European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia and Xgeva (denosumab) Biosimilar Candidate HLX14 (Business Wire)
May-14-24 12:20PM	Surging Earnings Estimates Signal Upside for Organon (OGN) Stock (Zacks)
May-07-24 08:20PM	Organon Announces Pricing of $1.0 Billion Senior Notes Offering (Business Wire)
12:45PM	20 States with the Highest Fertility Rates in the US (Insider Monkey)
07:58AM	Organon Announces Proposed $1.0 Billion Senior Notes Offering (Business Wire)
May-03-24 12:37PM	Organon & Co. (NYSE:OGN) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-02-24 12:00PM	What Makes Organon (OGN) a New Buy Stock (Zacks)
08:55AM	Organon (OGN) Tops Q1 Earnings and Revenue Estimates (Zacks)
07:30AM	Organon Reports Results for the First Quarter Ended March 31, 2024 (Business Wire)
May-01-24 01:26PM	7 Sleeper Stocks to Buy Before Wall Street Wakes Up: April 2024 (InvestorPlace)
11:03AM	Organon (OGN) Gears Up to Report Q1 Earnings: What's in Store? (Zacks)
10:47AM	3 Healthcare Stocks With the Potential to Triple Your Investment by 2026 (InvestorPlace)
Apr-29-24 10:26AM	12 Under-the-Radar Stocks With Massive Upside for 2024 (Insider Monkey)
09:16AM	Stay Ahead of the Game With Organon (OGN) Q1 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Apr-25-24 10:01AM	Earnings Preview: Organon (OGN) Q1 Earnings Expected to Decline (Zacks)
Apr-22-24 06:15PM	Organon (OGN) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
Apr-21-24 10:39AM	11 Best Low Price Pharma Stocks To Invest In (Insider Monkey)
09:35AM	15 Best Affordable Dividend Stocks To Invest In Right Now (Insider Monkey)
Apr-12-24 11:08AM	5 Most Undervalued Stocks to Buy for Under $20 (Insider Monkey)
Apr-08-24 06:15AM	Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024 (Business Wire)
06:00AM	Phase 3 Comparative Clinical Study of Prolia and Xgeva (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoints (Business Wire)
Apr-01-24 04:05PM	Dar Bioscience, Inc. (NASDAQ:DARE) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-08-24 09:01AM	On International Women's Day, Organon Canada is encouraging businesses to Invest in HER and help address gender inequities through women's health (PR Newswire)
Mar-05-24 02:56AM	13 Best Pharma Dividend Stocks To Buy in 2024 (Insider Monkey)
Feb-20-24 08:00AM	Organon Announces HADLIMA (adalimumab-bwwd) Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National Formulary (Business Wire)
07:45AM	Organon Launches U.S. Grant Programs and Listening Tour as Part of 'Her Plan Is Her Power,' Reaching High-Need Communities To Help Reduce Unplanned Pregnancies (ACCESSWIRE)
Feb-16-24 09:47AM	Organon & Co. (NYSE:OGN) Q4 2023 Earnings Call Transcript (Insider Monkey)

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women's health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
COX CARRIE SMITH	Director	May 14 '25	Buy	8.07	12,469	100,591	12,469	May 15 04:09 PM
Falcione Aaron	Chief Human Resources Officer	May 07 '25	Buy	8.77	5,500	48,235	62,974	May 07 12:13 PM
Weaver Kirke	Gen. Counsel & Corp. Secy.	May 06 '25	Buy	9.21	8,045	74,054	52,489	May 07 12:12 PM
Karp Daniel	Executive VP, Corp. Dev.	May 06 '25	Buy	8.24	3,500	28,828	46,669	May 07 12:09 PM
WALSH MATTHEW M	Chief Financial Officer	May 05 '25	Buy	8.82	11,400	100,548	144,484	May 06 01:59 PM
Ali Kevin	Chief Executive Officer	May 05 '25	Buy	8.80	34,000	299,370	282,731	May 06 01:58 PM
Falcione Aaron	Chief Human Resources Officer	Mar 31 '25	Option Exercise	0.00	18,732	0	59,237	Apr 02 05:45 PM
Karp Daniel	Executive VP, Corp. Dev.	Mar 31 '25	Option Exercise	0.00	34,677	0	44,515	Apr 02 05:44 PM
Stahler Rachel A	Chief Information Officer	Mar 31 '25	Option Exercise	0.00	18,334	0	78,994	Apr 02 05:43 PM
WALSH MATTHEW M	Chief Financial Officer	Mar 31 '25	Option Exercise	0.00	34,870	0	136,903	Apr 02 05:41 PM
Arjona Ferreira Juan Camilo	Head of R&D & CMO	Mar 31 '25	Option Exercise	0.00	8,865	0	20,552	Apr 02 05:40 PM
Weaver Kirke	Gen. Counsel & Corp. Secy.	Mar 31 '25	Option Exercise	0.00	21,376	0	45,668	Apr 02 05:39 PM
DiMarco Kathryn	Corporate Controller	Mar 31 '25	Option Exercise	0.00	23,435	0	40,211	Apr 02 05:35 PM
Nisita Vittorio	Head of Global Business Svcs	Mar 31 '25	Option Exercise	0.00	13,231	0	44,803	Apr 02 05:34 PM
Morrissey Joseph T. Jr.	Head of Manufacturing	Mar 31 '25	Option Exercise	0.00	21,483	0	73,275	Apr 02 05:33 PM
Ali Kevin	Chief Executive Officer	Mar 31 '25	Option Exercise	0.00	109,204	0	260,687	Apr 02 05:32 PM
Arjona Ferreira Juan Camilo	Head of R&D & CMO	Nov 07 '24	Option Exercise	0.00	6,446	0	13,987	Nov 08 04:17 PM
Arjona Ferreira Juan Camilo	Head of R&D & CMO	Aug 11 '24	Option Exercise	0.00	11,519	0	11,532	Aug 12 05:18 PM

Open in Screener

TXN

Texas Instruments Inc

May 30 • 04:00PM ET

182.85

Dollar change -2.14
Percentage change -1.16	%

Technology • Semiconductors • USA • NASD

TXN Texas Instruments Inc daily Stock Chart

Peers: ADI ON MCHP AVGO SWKS QRVO NXPI STM AMD

| Held by: VTI VOO QQQ SCHD SPY IVV VUG XLK SMH VGT

Index	NDX, S&P 500	P/E	34.64	EPS (ttm)	5.28	Insider Own	0.17%	Shs Outstand	909.00M	Perf Week	1.46%
Market Cap	166.11B	Forward P/E	27.43	EPS next Y	6.67	Insider Trans	-24.62%	Shs Float	906.95M	Perf Month	14.25%
Income	4.85B	PEG	2.37	EPS next Q	1.34	Inst Own	87.65%	Short Float	2.50%	Perf Quarter	-6.70%
Sales	16.05B	P/S	10.35	EPS this Y	6.33%	Inst Trans	-0.44%	Short Ratio	2.75	Perf Half Y	-9.90%
Book/sh	18.05	P/B	10.13	EPS next Y	20.55%	ROA	14.13%	Short Interest	22.72M	Perf Year	-8.39%
Cash/sh	5.51	P/C	33.19	EPS next 5Y	14.61%	ROE	29.04%	52W Range	139.95 - 220.38	Perf YTD	-2.49%
Dividend Est.	5.48 (3.00%)	P/FCF	114.17	EPS past 5Y	-0.16%	ROI	16.57%	52W High	-17.03%	Beta	1.00
Dividend TTM	5.38 (2.94%)	Quick Ratio	3.37	Sales past 5Y	2.67%	Gross Margin	58.02%	52W Low	30.65%	ATR (14)	5.58
Dividend Ex-Date	Apr 30, 2025	Current Ratio	5.26	EPS Y/Y TTM	-17.82%	Oper. Margin	34.29%	RSI (14)	57.09	Volatility	2.11% 2.63%
Employees	34000	Debt/Eq	0.78	Sales Y/Y TTM	-4.48%	Profit Margin	30.21%	Recom	2.59	Target Price	177.52
Option/Short	Yes / Yes	LT Debt/Eq	0.78	EPS Q/Q	6.75%	Payout	101.23%	Rel Volume	1.83	Prev Close	184.99
Sales Surprise	4.12%	EPS Surprise	19.45%	Sales Q/Q	11.14%	Earnings	Apr 23 AMC	Avg Volume	8.25M	Price	182.85
SMA20	2.03%	SMA50	7.71%	SMA200	-3.74%	Trades		Volume	15,098,966	Change	-1.16%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-30-25	Initiated	Seaport Research Partners	Sell	$130
Apr-25-25	Upgrade	DZ Bank	Sell → Hold	$163
Apr-24-25	Downgrade	Summit Insights	Buy → Hold
Apr-22-25	Downgrade	Barclays	Equal Weight → Underweight	$125
Apr-07-25	Upgrade	Robert W. Baird	Neutral → Outperform	$175
Nov-22-24	Initiated	Wells Fargo	Equal Weight	$215
Oct-23-24	Upgrade	Summit Insights	Hold → Buy
Aug-21-24	Upgrade	Citigroup	Neutral → Buy	$200 → $235
May-16-24	Initiated	Wells Fargo	Underweight	$150
May-13-24	Downgrade	Jefferies	Buy → Hold	$200 → $175
Apr-24-24	Reiterated	TD Cowen	Hold	$160 → $175
Apr-16-24	Initiated	Evercore ISI	Outperform	$213
Jan-24-24	Reiterated	TD Cowen	Market Perform	$145 → $160
Jan-23-24	Initiated	Cantor Fitzgerald	Neutral	$180
Jan-19-24	Upgrade	UBS	Neutral → Buy	$170 → $195
Oct-11-23	Downgrade	Oppenheimer	Outperform → Perform
Aug-30-23	Downgrade	Bernstein	Mkt Perform → Underperform	$145
Jul-20-23	Initiated	Wolfe Research	Peer Perform
Apr-24-23	Reiterated	Oppenheimer	Outperform	$185 → $195
Jan-23-23	Reiterated	Truist	Hold	$158 → $177

Show Previous Ratings

May-28-25 05:50PM	Why the Market Dipped But Texas Instruments (TXN) Gained Today (Zacks)
09:00AM	Investors Heavily Search Texas Instruments Incorporated (TXN): Here is What You Need to Know (Zacks)
06:20AM	Is iShares Semiconductor ETF (SOXX) a Strong ETF Right Now? (Zacks)
May-23-25 11:30AM	Why Is Texas Instruments (TXN) Up 11.2% Since Last Earnings Report? (Zacks)
May-22-25 11:01AM	This Chip Stock Is Soaring on an Nvidia Partnership (Investopedia)
10:39PM	Loading…
May-21-25 10:39PM	Texas Instruments champions safe, scalable humanoid robotics at Computex 2025 (DigiTimes)
May-20-25 05:40PM	Texas Instruments prices $1.2 billion of investment grade notes (PR Newswire)
May-19-25 01:10PM	TI Chief Financial Officer Rafael Lizardi to speak at Bank of America investor conference (PR Newswire)
08:50AM	These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
May-18-25 07:08AM	Was Jim Cramer Right About Texas Instruments (TXN) Stock? (Insider Monkey)
May-14-25 11:15AM	TI CEO Haviv Ilan to speak at Bernstein investor conference (PR Newswire)
10:35AM	Texas Instruments (TXN): Among the Best Dividend Growth Stocks with High Yields (Insider Monkey)
09:00AM	Texas Instruments Incorporated (TXN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
May-13-25 11:29AM	The Zacks Analyst Blog Highlights Texas Instruments, Boeing, NextEra (Zacks)
09:16AM	Interpreting Texas Instruments (TXN) International Revenue Trends (Zacks)
04:18PM	Loading…
May-12-25 04:18PM	Top Research Reports for Texas Instruments, Boeing & NextEra Energy (Zacks) +8.71%
08:32AM	Is the Options Market Predicting a Spike in Texas Instruments Stock? (Zacks)
May-10-25 04:20AM	Texas Instruments Incorporated (TXN): Among the Best High-Yield Dividend Stocks for 2025 and Beyond (Insider Monkey)
May-08-25 12:36AM	3 Volatile Stocks Facing Headwinds (StockStory)
May-07-25 10:10AM	Texas Instruments (TXN) Outperformed Amid Sector Weakness and Strategic Investments (Insider Monkey)
May-05-25 02:24PM	ON Semiconductor's Annual Revenue Slide Overshadows Beat (GuruFocus.com)
08:55AM	Zacks Industry Outlook Highlights NVIDIA and Texas Instruments (Zacks)
May-02-25 03:25PM	Geopolitics, AI Drive Prospects in Semiconductors: 2 Stocks (Zacks)
09:30AM	Surging Tariffs Are Flipping The Chip Script (Seeking Alpha)
May-01-25 05:37PM	Texas Instruments Incorporated (TXN): Jim Cramer Left Wishful - "Texan Is So Non-Promotional" (Insider Monkey)
Apr-30-25 11:27PM	Franklin Rising Dividends Fund Q1 2025 Commentary (Seeking Alpha)
Apr-29-25 05:39PM	Texas Instruments: Sell The Bounce (Technical Analysis, Rating Downgrade) (Seeking Alpha)
09:00AM	Texas Instruments Incorporated (TXN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
05:48AM	Texas Instruments Inc.: Not Keen To Invest At The Current Valuation (Seeking Alpha)
03:09AM	Qualcomm (QCOM) Q1 Earnings: What To Expect (StockStory)
03:05AM	Loading…
03:05AM	Earnings To Watch: Western Digital (WDC) Reports Q1 Results Tomorrow (StockStory)
Apr-28-25 04:51PM	Why Wolfspeed Rocketed 27% Higher (Again) on Monday (Motley Fool)
03:07AM	Qorvo (QRVO) Q1 Earnings Report Preview: What To Look For (StockStory)
03:04AM	Earnings To Watch: Seagate Technology (STX) Reports Q1 Results Tomorrow (StockStory)
Apr-27-25 08:00AM	Texas Instruments: Earnings Beat, Upbeat Guidance Fuel Recovery (MarketBeat)
03:01AM	NXP Semiconductors (NXPI) Reports Earnings Tomorrow: What To Expect (StockStory)
03:01AM	Amkor Earnings: What To Look For From AMKR (StockStory)
03:00AM	Teradyne (TER) Reports Q1: Everything You Need To Know Ahead Of Earnings (StockStory)
Apr-26-25 05:31PM	TXN Q1 Earnings Call: Industrial Recovery and Tariff Risks Shape Outlook (StockStory)
01:53AM	Dividend Champion, Contender, And Challenger Highlights: Week Of April 27 (Seeking Alpha)
Apr-25-25 09:38PM	TI partners with Taiwanese firms to showcase automotive tech at 2025 Taipei AMPA (DigiTimes)
07:51PM	Analyst Report: Texas Instruments Incorporated (Morningstar Research)
04:31PM	Jim Cramer Applauds Texas Instruments (TXN): "Put Up Terrific Numbers" (Insider Monkey)
04:24PM	Texas Instruments Incorporated (TXN): Among the Best Dividend Stocks to Buy for Long-Term Passive Income (Insider Monkey)
11:19AM	STMicroelectronics Q1 Earnings Review: Bottoming Out, But Visibility Still Too Low (Seeking Alpha)
08:50AM	These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Apr-24-25 04:49PM	These Stocks Moved the Most Today: Tesla, IBM, ServiceNow, Texas Instruments, Newmont, Southwest Airlines, and More (Barrons.com) +6.56%
03:48PM	Texas Instruments Pops on Strong Q1 Beat -- JPMorgan Sees Long-Term Upside Despite Target Cut (GuruFocus.com)
02:48PM	Why Are Texas Instruments (TXN) Shares Soaring Today (StockStory)
02:47PM	Wall Street Rally Powers On as Fed-Cut Wagers Grow: Markets Wrap (Bloomberg)
02:36PM	These Stocks Are Moving the Most Today: Tesla, IBM, ServiceNow, Texas Instruments, Newmont, Southwest Airlines, and More (Barrons.com)
01:14PM	Texas Instruments Q1: Better Than Feared For Now (Seeking Alpha)
12:11PM	Netflix's new high, Bristol Myers outlook, Texas Instruments pops (Yahoo Finance Video)
12:09PM	Texas Instruments Gains After Forecast Shows Recovery From Slump (Bloomberg)
11:50AM	Top Stock Movers Now: ServiceNow, Hasbro, IBM, and More (Investopedia)
11:41AM	B. Riley downgrades ON Semi to Neutral, slashes target by $32 on macro risk (Investing.com)
11:07AM	Texas Instruments Stock Rises on Q1 Earnings and Revenue Beat (Zacks)
10:09AM	Texas Instruments Stock Jumps After Earnings. Why Tariffs Are Still a Risk for the Chip Maker. (Barrons.com)
09:37AM	Merck, Nokia, Texas Instruments: Trending Tickers (Yahoo Finance Video)
09:34AM	Texas Instruments, Mondelez downgraded: Wall Street's top analyst calls (The Fly)
07:47AM	Q1 2025 Texas Instruments Inc Earnings Call (Thomson Reuters StreetEvents)
03:06AM	Texas Instruments Inc (TXN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market ... (GuruFocus.com)
02:58AM	Texas Instruments navigates uncertainty with strong results and optimistic outlook (DigiTimes)
Apr-23-25 11:37PM	Analyst Report: Texas Instruments Incorporated (Morningstar Research)
07:54PM	Texas Instruments Incorporated (TXN) Q1 2025 Earnings Call Transcript (Seeking Alpha)
06:44PM	Markets in Green 2nd Straight Day; Q1 Reports for CMG, IBM & More (Zacks)
06:34PM	Q3 will be a better read on tariff impact for Texas Instruments, says Stifel's Svanberg (CNBC TV)
05:33PM	Texas Instruments stock spikes in extended trading on quarterly beat (CNBC TV)
05:30PM	Here's What Key Metrics Tell Us About Texas Instruments (TXN) Q1 Earnings (Zacks)
05:10PM	Texas Instruments (TXN) Tops Q1 Earnings and Revenue Estimates (Zacks)
05:10PM	Texas Instruments Stock Climbs on Better-Than-Expected Earnings, Outlook (Investopedia)
05:05PM	Texas Instruments Reports Strong Earnings. The Stock Is Rising but Tariffs Are Still a Risk. (Barrons.com)
04:23PM	Texas Instruments (NASDAQ:TXN) Delivers Strong Q1 Numbers, Stock Soars (StockStory)
04:11PM	Chipmaker TI's rosy forecast soothes tariff worries, for now (Reuters)
04:08PM	Texas Instruments: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	TI reports first quarter 2025 financial results and shareholder returns (PR Newswire)
07:46AM	Texas Instruments Inc: The Dividend "Aristocrat" in the Making (GuruFocus.com)
12:30AM	Texas Instruments Earnings Are Today. Tariffs Will Make or Break the Chip Stock. (Barrons.com)
Apr-22-25 06:23PM	2 Semiconductor Reports to Watch This Week (Zacks)
09:46AM	Barclays downgrades Texas Instruments on China risk, demand concerns (Investing.com)
08:07AM	Texas Instruments (TXN) Reports Q1: Everything You Need To Know Ahead Of Earnings (StockStory)
Apr-21-25 12:32PM	3 Chip Stocks That Face Tariff Risks, According to Analyst (Barrons.com)
11:02AM	Wall Street Lunch: Dollar On Back Foot Amid Fed Independence Concerns (Seeking Alpha)
10:35AM	Texas Instruments to Post Q1 Earnings: What's in Store for the Stock? (Zacks)
05:26AM	Should You Invest in Qualcomm Incorporated? A Detailed Stock Breakdown (GuruFocus.com)
Apr-17-25 05:06PM	Texas Instruments board declares second quarter 2025 quarterly dividend (PR Newswire)
10:38AM	Texas Instruments Incorporated (TXN) 2025 Annual Meeting of Stockholders Transcript (Seeking Alpha)
09:26AM	TSMC Q1 2025 Earnings Silence Tariff Doubts (Seeking Alpha)
09:15AM	Gear Up for Texas Instruments (TXN) Q1 Earnings: Wall Street Estimates for Key Metrics (Zacks)
08:38AM	This chip stock is clearly the most popular long, Citi says (not Nvidia) (Investing.com)
08:10AM	My Dividend Stock Portfolio: New All-Time Dividend Record In March - 100 Holdings With 15 Buys (Seeking Alpha)
Apr-16-25 09:00AM	TSMC: Tariffs Or Not, Why I'm Betting On The Foundry Leader (Seeking Alpha)
Apr-15-25 06:00PM	Why the Market Dipped But Texas Instruments (TXN) Gained Today (Zacks)
02:30AM	TI enables automakers to advance vehicle autonomy and safety with new chips in its automotive portfolio (PR Newswire)
Apr-14-25 10:28AM	Amtech Stock Plummets 31% YTD: Should Investors Hold or Fold? (Zacks)
Apr-13-25 08:53PM	Is Texas Instruments Incorporated (TXN) the Best Technology Dividend Stock to Invest in? (Insider Monkey)
Apr-12-25 02:48AM	Why Texas Instruments Incorporated (TXN) Went Down On Friday? (Insider Monkey)
Apr-11-25 05:24PM	S&P 500 Gains and Losses Today: Newmont Shares Soar as Gold Hits Fresh High (Investopedia) -5.75%
05:12PM	Intel Faces Fresh Pressure as China Targets U.S.-Made Chips in Trade Salvo (GuruFocus.com)
03:49PM	Texas Instruments (TXN) Stock Trades Down, Here Is Why (StockStory)

Texas Instruments Incorporated engages in the design and manufacture of semiconductors. It operates through the following segments: Analog, Embedded Processing, and Other. The Analog segment semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. The Embedded Processing segment involves handling specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application. The company was founded in 1930 and is headquartered in Dallas, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
TEMPLETON RICHARD K	Chairman	Feb 27 '25	Option Exercise	52.93	97,000	5,134,210	506,089	Mar 03 04:28 PM
TEMPLETON RICHARD K	Chairman	Feb 28 '25	Option Exercise	52.93	4,557	241,202	413,646	Mar 03 04:28 PM
TEMPLETON RICHARD K	Chairman	Feb 27 '25	Sale	195.47	97,000	18,960,307	409,089	Mar 03 04:28 PM
TEMPLETON RICHARD K	Chairman	Feb 28 '25	Sale	194.21	4,557	885,021	409,089	Mar 03 04:28 PM
TEMPLETON RICHARD K	Chairman	Feb 25 '25	Option Exercise	52.93	97,000	5,134,210	506,089	Feb 27 04:39 PM
TEMPLETON RICHARD K	Chairman	Feb 26 '25	Option Exercise	52.93	97,000	5,134,210	506,089	Feb 27 04:39 PM
TEMPLETON RICHARD K	Chairman	Feb 25 '25	Sale	200.72	97,000	19,469,888	409,089	Feb 27 04:39 PM
TEMPLETON RICHARD K	Chairman	Feb 26 '25	Sale	197.69	97,000	19,175,569	409,089	Feb 27 04:39 PM
CLARK JANET F	Director	Feb 24 '25	Option Exercise	79.26	6,065	480,712	16,881	Feb 25 05:29 PM
CLARK JANET F	Director	Feb 24 '25	Sale	203.62	6,065	1,234,956	10,816	Feb 25 05:29 PM
TEMPLETON RICHARD K	Chairman	Feb 21 '25	Option Exercise	52.93	97,000	5,134,210	506,089	Feb 25 05:26 PM
TEMPLETON RICHARD K	Chairman	Feb 24 '25	Option Exercise	52.93	97,000	5,134,210	506,089	Feb 25 05:26 PM
TEMPLETON RICHARD K	Chairman	Feb 21 '25	Sale	202.72	97,000	19,663,684	409,089	Feb 25 05:26 PM
TEMPLETON RICHARD K	Chairman	Feb 24 '25	Sale	202.68	97,000	19,660,139	409,089	Feb 25 05:26 PM
Janet Clark	Director	Feb 24 '25	Proposed Sale	203.46	6,065	1,234,000		Feb 24 03:15 PM
Richard K Templeton	Other: Chairman of the Board	Feb 21 '25	Proposed Sale	202.00	489,557	98,890,514		Feb 21 05:39 PM
BLINN MARK A	Director	Feb 19 '25	Option Exercise	171.55	6,186	1,061,238	17,903	Feb 20 04:05 PM
BLINN MARK A	Director	Feb 19 '25	Sale	189.89	6,186	1,174,646	11,717	Feb 20 04:05 PM
Leonard Shanon J	Sr. Vice President	Feb 18 '25	Sale	186.62	2,150	401,241	27,016	Feb 19 04:08 PM
MARK A BLINN	Officer	Feb 19 '25	Proposed Sale	189.89	6,186	1,174,646		Feb 19 02:46 PM
Shanon J. Leonard	Officer	Feb 18 '25	Proposed Sale	186.51	2,150	401,000		Feb 18 05:28 PM
BLINN MARK A	Director	Feb 04 '25	Sale	180.71	590	106,617	11,717	Feb 05 04:30 PM
MARK A BLINN	Officer	Feb 04 '25	Proposed Sale	180.63	590	106,574		Feb 04 04:54 PM
KIRK RONALD	Director	Nov 25 '24	Option Exercise	53.94	10,539	568,474	24,862	Nov 26 04:05 PM
KIRK RONALD	Director	Nov 25 '24	Sale	203.33	10,539	2,142,910	14,323	Nov 26 04:05 PM
RONALD KIRK	Officer	Nov 25 '24	Proposed Sale	203.33	10,539	2,142,909		Nov 25 02:31 PM
Lizardi Rafael R	Sr. Vice President & CFO	Nov 07 '24	Option Exercise	105.99	46,917	4,972,771	120,978	Nov 13 04:21 PM
Lizardi Rafael R	Sr. Vice President & CFO	Nov 07 '24	Sale	217.16	46,917	10,188,294	74,061	Nov 13 04:21 PM
Ilan Haviv	President & CEO	Nov 08 '24	Option Exercise	79.26	13,151	1,042,348	138,837	Nov 13 04:12 PM
Ilan Haviv	President & CEO	Nov 08 '24	Sale	219.30	13,151	2,884,026	125,686	Nov 13 04:12 PM
Yunus Mohammad	Sr. Vice President	Nov 07 '24	Option Exercise	106.26	8,358	888,111	37,282	Nov 13 04:08 PM
Yunus Mohammad	Sr. Vice President	Nov 07 '24	Sale	216.94	8,358	1,813,145	28,924	Nov 13 04:08 PM
BAHAI AHMAD	Sr. Vice President	Nov 07 '24	Option Exercise	79.26	2,175	172,390	37,225	Nov 13 04:07 PM
BAHAI AHMAD	Sr. Vice President	Nov 07 '24	Sale	217.25	2,175	472,514	35,050	Nov 13 04:07 PM
Gary Mark	Sr. Vice President	Nov 08 '24	Option Exercise	104.41	15,865	1,656,465	53,791	Nov 13 04:04 PM
Gary Mark	Sr. Vice President	Nov 08 '24	Sale	219.82	15,865	3,487,419	37,926	Nov 13 04:04 PM
Haviv Ilan	Officer	Nov 08 '24	Proposed Sale	219.29	13,151	2,883,905		Nov 08 05:05 PM
Gary Mark	Sr. Vice President	Nov 06 '24	Sale	214.83	4,377	940,296	37,926	Nov 08 04:42 PM
Witzsche Christine	Sr. Vice President	Nov 06 '24	Option Exercise	53.94	132	7,120	17,609	Nov 08 04:36 PM
Witzsche Christine	Sr. Vice President	Nov 06 '24	Sale	211.68	132	27,941	17,477	Nov 08 04:36 PM
Ilan Haviv	President & CEO	Nov 06 '24	Option Exercise	79.26	25,000	1,981,500	150,686	Nov 08 04:33 PM
Ilan Haviv	President & CEO	Nov 06 '24	Sale	211.50	25,000	5,287,595	125,686	Nov 08 04:33 PM
RAFAEL R. LIZARDI	Officer	Nov 07 '24	Proposed Sale	217.16	46,917	10,188,293		Nov 07 04:43 PM
Haviv Ilan	Officer	Nov 06 '24	Proposed Sale	211.50	25,000	5,287,596		Nov 06 05:27 PM
CHRISTINE WITZSCHE	Officer	Nov 06 '24	Proposed Sale	211.67	132	27,941		Nov 06 04:36 PM
SANCHEZ ROBERT E	Director	Oct 25 '24	Option Exercise	52.93	9,990	528,771	30,451	Oct 29 05:10 PM
SANCHEZ ROBERT E	Director	Oct 25 '24	Sale	208.80	9,990	2,085,871	20,461	Oct 29 05:10 PM
Robert E Sanchez	Officer	Oct 25 '24	Proposed Sale	208.79	9,990	2,085,773		Oct 25 04:29 PM
PATSLEY PAMELA H	Director	Aug 29 '24	Option Exercise	79.26	6,065	480,712	39,413	Sep 03 04:34 PM
PATSLEY PAMELA H	Director	Aug 29 '24	Sale	212.43	6,065	1,288,388	33,348	Sep 03 04:34 PM
Gary Mark	Sr. Vice President	Aug 29 '24	Option Exercise	79.26	15,165	1,201,978	60,308	Sep 03 04:33 PM
Gary Mark	Sr. Vice President	Aug 29 '24	Sale	212.63	15,165	3,224,484	45,143	Sep 03 04:33 PM
Roberts Mark T.	Sr. Vice President	Aug 29 '24	Sale	213.08	4,700	1,001,498	47,369	Sep 03 04:32 PM
Ron Amichai	Sr. Vice President	Aug 29 '24	Option Exercise	110.15	12,921	1,423,248	76,162	Sep 03 04:29 PM
Ron Amichai	Sr. Vice President	Aug 29 '24	Sale	213.72	12,921	2,761,472	63,241	Sep 03 04:29 PM
BAHAI AHMAD	Sr. Vice President	Aug 27 '24	Option Exercise	68.42	4,250	290,778	39,270	Aug 29 05:44 PM
BAHAI AHMAD	Sr. Vice President	Aug 27 '24	Sale	209.98	4,250	892,427	35,020	Aug 29 05:44 PM
PAMELA H PATSLEY	Officer	Aug 29 '24	Proposed Sale	212.43	6,065	1,288,388		Aug 29 05:22 PM
Yunus Mohammad	Sr. Vice President	Aug 26 '24	Sale	208.90	3,778	789,215	28,894	Aug 28 05:41 PM
Ilan Haviv	President & CEO	Aug 26 '24	Sale	209.44	1,200	251,324	158,676	Aug 28 05:37 PM
Knecht Julie C.	VP & Chief Accounting Officer	Aug 23 '24	Option Exercise	106.80	7,764	829,185	19,570	Aug 27 04:37 PM
Knecht Julie C.	VP & Chief Accounting Officer	Aug 23 '24	Sale	209.49	7,764	1,626,479	11,806	Aug 27 04:37 PM
Leonard Shanon J	Sr. Vice President	Aug 23 '24	Sale	208.91	2,816	588,301	24,112	Aug 27 04:34 PM
Gary Mark	Sr. Vice President	Aug 23 '24	Sale	207.20	4,532	939,037	45,143	Aug 27 04:30 PM
Hobby Jean M.	Director	Aug 22 '24	Option Exercise	103.04	18,814	1,938,668	24,727	Aug 26 04:54 PM
Hobby Jean M.	Director	Aug 22 '24	Sale	205.71	21,239	4,369,179	3,488	Aug 26 04:54 PM
SHANON J. LEONARD	Officer	Aug 23 '24	Proposed Sale	208.91	2,816	588,301		Aug 23 04:24 PM
JEAN M HOBBY	Officer	Aug 22 '24	Proposed Sale	205.71	21,239	4,369,074		Aug 22 05:38 PM

OGN

Organon & Co

TXN

Texas Instruments Inc

Upgrade your FINVIZ experience